• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON CLAREON PANOPTIX TRIFOCAL UV ABSORBING INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON CLAREON PANOPTIX TRIFOCAL UV ABSORBING INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR Back to Search Results
Model Number CCWTT0
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); Visual Impairment (2138)
Date of Event 02/19/2024
Type of Reportable Event Serious Injury
Event or Problem Description
A certified ophthalmic technician reported that after intraocular lens (iol) implantation, the patient could not get used to the loss of contrast with the implanted iol, neither distance nor near vision was clear.The lens was removed and replaced with a non-company lens in a secondary procedure.The clinical reason for explant was "slight hyperopic result".
 
Additional Manufacturer Narrative
The lens was returned in a specimen cup.Blood and solution was dried on the lens.The optic had a large deep crack in the central optic zone.Power and resolution testing could not be conducted due to the extensive optic damage.Complaint history and product history records were reviewed, and documentation indicated the product met release criteria.Qualified associated products were indicated.The product investigation could not identify a root cause for the reported complaint.Power and resolution testing could not be conducted due to the extensive optic damage.The power and resolution of each lens is 100% evaluated during the manufacturing process to determine acceptability per model and diopter.Information was provided in the file; "in the surgeons opinion the patient couldn¿t get used to the loss of contrast with company intraocular lens (iol)".The multifocal company 17.0 diopter, add power +2.2 & 3.2 lens model was replaced with a non-company monofocal 17.5 diopter lens.Due to the exchange of a multifocal lens to a monofocal lens may suggest that the replacement lens model was an improved choice for the patient's vision needs.No additional information has been provided at this time.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON PANOPTIX TRIFOCAL UV ABSORBING INTRAOCULAR LENS
Common Device Name
LENS, MULTIFOCAL INTRAOCULAR
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key19123939
Report Number1119421-2024-00728
Device Sequence Number8359972
Product Code MFK
UDI-Device Identifier00380652413589
UDI-Public00380652413589
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 04/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/08/2025
Device Model NumberCCWTT0
Device Catalogue NumberCCWTT0.170
Device Lot Number15287999
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/03/2024
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/20/2024
Initial Report FDA Received Date04/17/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/15/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DUOVISC VISCOELASTIC SYSTEM; DXR00V +17.5SYMFONY OPTIBLUE SN: (B)(6); MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE C; MONARCH III IOL DELIVERY SYSTEM, INJECTOR
Outcome Attributed to Adverse Event Required Intervention;
Patient Age70 YR
Patient SexUnknown
-
-